Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Chamorey

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Cancer|July 11, 2006
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancerJean-Marc Ferrero, Emmanuel Chamorey, Stephane Oudard, et al.
Surgical Oncology|April 16, 2021
Long-term functional and quality of life outcomes in laryngectomized patients after successful voice restoration using tracheoesophageal prosthesesAlexandre Bozec, Maxime Boscagli, Marilou Serris, et al.
Journal of Clinical Medicine|June 28, 2023
Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell CarcinomasRoxane Elaldi, Emmanuel Chamorey, Renaud Schiappa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2015
Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trialJean-Pierre Gérard, Emmanuel Chamorey, Sophie Gourgou-Bourgade, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 11, 2007
Head and neck reconstruction with free flaps: a report on 213 casesOlivier Dassonville, Gilles Poissonnet, Emmanuel Chamorey, et al.
Bulletin Du Cancer|April 26, 2021
[Cross-cultural adaptation of the French version of the thyroid cancer-specific quality of life questionnaire: THYCA-QoL]Boris Scheller, Joseph Santini, Amélie Anota, et al.
Investigational New Drugs|June 6, 2020
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Head & Neck|August 11, 2016
Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancerAlexandre Bozec, Nathalie Ebran, Nina Radosevic-Robin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 18, 2013
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancerCédric S Pierre, Olivier Dassonville, Emmanuel Chamorey, et al.
Cancer Research|December 17, 2013
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinomaRenaud Grépin, Mélanie Guyot, Sandy Giuliano, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Cancer|July 11, 2006
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancerJean-Marc Ferrero, Emmanuel Chamorey, Stephane Oudard, et al.
Surgical Oncology|April 16, 2021
Long-term functional and quality of life outcomes in laryngectomized patients after successful voice restoration using tracheoesophageal prosthesesAlexandre Bozec, Maxime Boscagli, Marilou Serris, et al.
Journal of Clinical Medicine|June 28, 2023
Comparative Performance of Four Staging Classifications to Select «High-Risk» Head and Neck Cutaneous Squamous Cell CarcinomasRoxane Elaldi, Emmanuel Chamorey, Renaud Schiappa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2015
Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trialJean-Pierre Gérard, Emmanuel Chamorey, Sophie Gourgou-Bourgade, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 11, 2007
Head and neck reconstruction with free flaps: a report on 213 casesOlivier Dassonville, Gilles Poissonnet, Emmanuel Chamorey, et al.
Bulletin Du Cancer|April 26, 2021
[Cross-cultural adaptation of the French version of the thyroid cancer-specific quality of life questionnaire: THYCA-QoL]Boris Scheller, Joseph Santini, Amélie Anota, et al.
Investigational New Drugs|June 6, 2020
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Head & Neck|August 11, 2016
Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancerAlexandre Bozec, Nathalie Ebran, Nina Radosevic-Robin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 18, 2013
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancerCédric S Pierre, Olivier Dassonville, Emmanuel Chamorey, et al.
Cancer Research|December 17, 2013
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinomaRenaud Grépin, Mélanie Guyot, Sandy Giuliano, et al.
Pageof 16